Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.

MLA

Li, Cui, et al. “Expression of the Immune Checkpoint Molecules CD226 and TIGIT in Preeclampsia Patients.” BMC Immunology, vol. 25, no. 1, Feb. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12865-024-00603-5.

APA

Li, C., Liu, H., & Duan, Z. (2024). Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients. BMC Immunology, 25(1), 1–7. https://doi.org/10.1186/s12865-024-00603-5

Chicago

Li, Cui, Haiyan Liu, and Zhongliang Duan. 2024. “Expression of the Immune Checkpoint Molecules CD226 and TIGIT in Preeclampsia Patients.” BMC Immunology 25 (1): 1–7. doi:10.1186/s12865-024-00603-5.